ACCORD HEALTHCARE LAUNCH PRASUGREL

Accord Healthcare is delighted to announce the launch of Prasugrel Accord 10 mg which is available in a pack size of 28 tablets.

This medicine, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndrome (i.e. unstable angina, non-ST segment elevation myocardial infarction [UA/NSTEMI] or ST segment elevation myocardial infarction [STEMI]) undergoing primary or delayed percutaneous coronary intervention (PCI).

Please refer to the Summary of Product Characteristics (SPC) for further information. The SPC will be available from the launch date at www.hpra.ie and for Healthcare Professionals at www.accord-healthcare.ie.

For further information please contact Accord in Cork on 021-461 9040 or visit www.accord-healthcare.ie

Leave a Reply

Your email address will not be published. Required fields are marked *

Please Confirm

This website is only for the eyes of medical professionals. Are you a medical professional?